Implantation of a posterior chamber phakic intraocular lens on Bruch's membrane opening-minimum rim width, retinal nerve fiber layer, and macular thickness.

IF 1.8 4区 医学 Q2 OPHTHALMOLOGY
International journal of ophthalmology Pub Date : 2025-09-18 eCollection Date: 2025-01-01 DOI:10.18240/ijo.2025.09.06
Josefina Reñones, Humberto Carreras, Alfonso Antón-López, Ángel García-García, Rafael Melián, Juan Francisco Loro-Ferrer, David P Piñero
{"title":"Implantation of a posterior chamber phakic intraocular lens on Bruch's membrane opening-minimum rim width, retinal nerve fiber layer, and macular thickness.","authors":"Josefina Reñones, Humberto Carreras, Alfonso Antón-López, Ángel García-García, Rafael Melián, Juan Francisco Loro-Ferrer, David P Piñero","doi":"10.18240/ijo.2025.09.06","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To assess whether the implantation of a posterior chamber phakic intraocular lens produces changes in optical coherence tomography (OCT) measurements of macular thickness (MT) and two parameters that define the structure of the optic nerve, the peripapillary nerve fiber layer (RNFL) and the Bruch's membrane opening-minimum rim width (BMO-MRW).</p><p><strong>Methods: </strong>This nonrandomized prospective pre-post study included 86 eyes of 48 patients (age, 20-47y; axial length: 23.10-28.95 mm) scheduled for myopia or myopic astigmatism correction with implantation of the implantable collamer lens (ICL). Eyes with glaucoma or any other ocular disease that could alter OCT results were excluded. RNFL, BMO-MRW and MT were measured preoperatively, and at 1 and 6mo after surgery using spectral-domain OCT. Changes between preoperative and postoperative values were evaluated.</p><p><strong>Results: </strong>There was a significant increase in BMO-MRW at 1mo (mean change: 3.48±15.07 µm, <i>P</i>=0.041). No significant changes were found during the rest of follow-up (1-6mo postop., <i>P</i>=0.623). There was also a significant increase in RNFL thickness at 1mo after surgery (1.45±2.18 µm, <i>P</i><0.001), but with a significant reduction from 1 to 6mo postoperatively (<i>P</i>=0.002). Regarding MT, it increased significantly at 1mo (2.46±3.76 µm, <i>P</i><0.001), with a significant decrease afterwards (<i>P</i>=0.048). Measurements of the three parameters at 6mo were slightly superior to preoperative values (<i>P</i><0.01).</p><p><strong>Conclusion: </strong>Minimal changes are induced in BMO-MRW, RNFL and MT after ICL implantation in healthy eyes, confirming the safety of the surgical procedure regarding the structure of the optic nerve head and the macula, and indicating that this phakic intraocular lens seems to have a slight impact on OCT measurements.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"18 9","pages":"1658-1664"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12378668/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18240/ijo.2025.09.06","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To assess whether the implantation of a posterior chamber phakic intraocular lens produces changes in optical coherence tomography (OCT) measurements of macular thickness (MT) and two parameters that define the structure of the optic nerve, the peripapillary nerve fiber layer (RNFL) and the Bruch's membrane opening-minimum rim width (BMO-MRW).

Methods: This nonrandomized prospective pre-post study included 86 eyes of 48 patients (age, 20-47y; axial length: 23.10-28.95 mm) scheduled for myopia or myopic astigmatism correction with implantation of the implantable collamer lens (ICL). Eyes with glaucoma or any other ocular disease that could alter OCT results were excluded. RNFL, BMO-MRW and MT were measured preoperatively, and at 1 and 6mo after surgery using spectral-domain OCT. Changes between preoperative and postoperative values were evaluated.

Results: There was a significant increase in BMO-MRW at 1mo (mean change: 3.48±15.07 µm, P=0.041). No significant changes were found during the rest of follow-up (1-6mo postop., P=0.623). There was also a significant increase in RNFL thickness at 1mo after surgery (1.45±2.18 µm, P<0.001), but with a significant reduction from 1 to 6mo postoperatively (P=0.002). Regarding MT, it increased significantly at 1mo (2.46±3.76 µm, P<0.001), with a significant decrease afterwards (P=0.048). Measurements of the three parameters at 6mo were slightly superior to preoperative values (P<0.01).

Conclusion: Minimal changes are induced in BMO-MRW, RNFL and MT after ICL implantation in healthy eyes, confirming the safety of the surgical procedure regarding the structure of the optic nerve head and the macula, and indicating that this phakic intraocular lens seems to have a slight impact on OCT measurements.

在Bruch膜开口上植入后房型晶状体——最小边缘宽度、视网膜神经纤维层和黄斑厚度。
目的:评价后房型人工晶状体植入术是否对黄斑厚度(MT)的光学相干断层扫描(OCT)测量和视神经结构、乳头周围神经纤维层(RNFL)和布鲁氏膜开口-最小边缘宽度(BMO-MRW)的两个参数产生影响。方法:本研究纳入48例86眼(年龄20-47岁,眼轴长23.10-28.95 mm)的非随机前瞻性术前-术后研究,拟行植入式晶体(ICL)矫正近视或近视散光。患有青光眼或其他可能改变OCT结果的眼部疾病的眼睛被排除在外。术前测量RNFL, BMO-MRW和MT,并在术后1和6个月使用频谱域oct评估术前和术后值的变化。结果:BMO-MRW在1mo时显著升高(平均变化:3.48±15.07µm, P=0.041)。其余随访(术后1 ~ 6mo)未见明显变化。, P = 0.623)。术后1mo时RNFL厚度也显著增加(1.45±2.18µm, PP=0.002)。MT在1mo时显著升高(2.46±3.76µm, PP=0.048)。结论:健康眼ICL植入术后BMO-MRW、RNFL和MT变化很小,证实了手术对视神经头和黄斑结构的安全性,表明晶状体对OCT测量的影响似乎很小。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.50
自引率
7.10%
发文量
3141
审稿时长
4-8 weeks
期刊介绍: · International Journal of Ophthalmology-IJO (English edition) is a global ophthalmological scientific publication and a peer-reviewed open access periodical (ISSN 2222-3959 print, ISSN 2227-4898 online). This journal is sponsored by Chinese Medical Association Xi’an Branch and obtains guidance and support from WHO and ICO (International Council of Ophthalmology). It has been indexed in SCIE, PubMed, PubMed-Central, Chemical Abstracts, Scopus, EMBASE , and DOAJ. IJO JCR IF in 2017 is 1.166. IJO was established in 2008, with editorial office in Xi’an, China. It is a monthly publication. General Scientific Advisors include Prof. Hugh Taylor (President of ICO); Prof.Bruce Spivey (Immediate Past President of ICO); Prof.Mark Tso (Ex-Vice President of ICO) and Prof.Daiming Fan (Academician and Vice President, Chinese Academy of Engineering. International Scientific Advisors include Prof. Serge Resnikoff (WHO Senior Speciatist for Prevention of blindness), Prof. Chi-Chao Chan (National Eye Institute, USA) and Prof. Richard L Abbott (Ex-President of AAO/PAAO) et al. Honorary Editors-in-Chief: Prof. Li-Xin Xie(Academician of Chinese Academy of Engineering/Honorary President of Chinese Ophthalmological Society); Prof. Dennis Lam (President of APAO) and Prof. Xiao-Xin Li (Ex-President of Chinese Ophthalmological Society). Chief Editor: Prof. Xiu-Wen Hu (President of IJO Press). Editors-in-Chief: Prof. Yan-Nian Hui (Ex-Director, Eye Institute of Chinese PLA) and Prof. George Chiou (Founding chief editor of Journal of Ocular Pharmacology & Therapeutics). Associate Editors-in-Chief include: Prof. Ning-Li Wang (President Elect of APAO); Prof. Ke Yao (President of Chinese Ophthalmological Society) ; Prof.William Smiddy (Bascom Palmer Eye instituteUSA) ; Prof.Joel Schuman (President of Association of University Professors of Ophthalmology,USA); Prof.Yizhi Liu (Vice President of Chinese Ophtlalmology Society); Prof.Yu-Sheng Wang (Director of Eye Institute of Chinese PLA); Prof.Ling-Yun Cheng (Director of Ocular Pharmacology, Shiley Eye Center, USA). IJO accepts contributions in English from all over the world. It includes mainly original articles and review articles, both basic and clinical papers. Instruction is Welcome Contribution is Welcome Citation is Welcome Cooperation organization International Council of Ophthalmology(ICO), PubMed, PMC, American Academy of Ophthalmology, Asia-Pacific, Thomson Reuters, The Charlesworth Group, Crossref,Scopus,Publons, DOAJ etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信